Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2547
H.R.2547: Surrogate Endpoint Improvement and Utilization Act of 2015
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced May 21, 2015
- Latest Major Action May 22, 2015
Bill Sponsor
Bill Summary
Surrogate Endpoint Improvement and Utilization Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to allow the sponsor of a drug that is eligible for accelerated approval to request that the Food and Drug Administration (FDA) agree to an accelerated approval development plan that includes a surrogate endpoint for the study of the drug and a magnitude of drug effect that is sufficient to claim the drug is effective....
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| May 22, 2015 |
Referred to the Subcommittee on Health.
|
| May 21, 2015 |
Referred to the House Committee on Energy and Commerce.
|
| May 21, 2015 |
Introduced in the House by Cathy McMorris Rodgers (R-Wash.) |